• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
    • {%itemName%} {%arrowSpan%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for Healthcare Professionals


      Report Adverse Event

      Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

      Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.

      Adverse events should also be reported to AbbVie at:

      ABBV-RO-00032-MC.   Date of preparation: December 2020